Please login to the form below

Not currently logged in
Email:
Password:

ABPI's David Fisher defends drug pricing

ABPI commercial director, David Fisher has responded to criticism levied at the pharmaceutical industry over its pricing

The Association of the British Pharmaceutical Industry (ABPI) commercial director, David Fisher has responded to criticism levied at the pharmaceutical industry over its pricing. In a viewpoint published on the BBC website, he says that companies "are unfairly attacked".

Fisher also says that pharma risks "millions upon millions of pounds in order to find new medicines to treat people who are sick and dying and for whom there is currently no treatment. The odds of success," he points out, "are almost impossible".

He also refers to the Pharmaceutical Price Regulation Scheme (PPRS) and its remit to cap the profits that the pharma industry can make. He puts forward the argument that the price of medicines in the UK was slashed by 7 per cent in 2005, with a further 3.9 per cent reduction this year, and a 2.9 per cent decrease due in 2010, and adds that prices in the UK are amongst the lowest in Europe.

12th August 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics